Program
Thursday, 10 March 2016
Opening session
Chairs: E. Rietschel, Berlin / P. Suter, Geneva
10:30 Welcome and introduction
- W. Tiefensee, TMWWDG
- G. Berg, Leopoldina
- W. Rosenthal, FSU
- K. Benndorf, UKJ
10:50 Keynote Lecture "Role of poverty and environment for public health"
- A. Steiner, Executive Director of United Nations Environment Programme (UNEP) and Under-Secretary-General of the United Nations
11:20 The German strategy for infection and sepsis control
- L. H. Wieler, RKI
11:40 The WHO approach to sepsis control
- N. Shindo, WHO
12:00 Lessons to be learned from the Ebola epidemic
- T. Stöbe, MSF
12:20 The burden of sepsis in children
- N. Kissoon, Canada
12:40 The burden of sepsis - a call to action
- K. Reinhart, Jena
13:00 Lunch Break
The challenges of science
Chairs: M. Quintel, Göttingen / T. Hein, Dallas
14:00 Challenges in the development of novel diagnostics and therapeutics in sepsis
- N. Riedemann, Jena
14:20 Challenges to preserve and develop effective antimicrobials
- M. Pletz, Jena
14:40 Role and challenges of clinical sepsis research
- S. Finfer, Australia
15:00 Lessons learned from cancer
- M. Löffler, Leipzig
15:20 Lessons learned from cardiology
- C. Schulze, Jena
15:40 Coffee Break
Novel approaches to sepsis control and health promotion
Chairs: C. Spies, Berlin / R. Rossaint, Aachen
16:00 The Surviving Sepsis Campaign approach to guideline implementation
- H. Gerlach, Berlin
16:20 The National Irish initiative to sepsis control
- V. Hamilton, Ireland
16:40 The Scottish National Health Service approach to quality improvement
- K. Rooney, Scotland
Novel approaches to sepsis control and health promotion II
Chairs: K. Werdan, Halle / M. Weigand, Heidelberg
17:00 The NRC for Surveillance and Nosocomial infection’s approach
- P. Gastmeier, Berlin
17:20 The Initiative for Quality in Medicine’s approach
- A. Meier-Hellmann, Erfurt
17:40 The Center for Sepsis Control and Care’s approach
- H. Rüddel, Jena
18:00 The perspective of a sepsis victim
- A. Trumann, Heeslingen
Öffentlicher Abendvortrag
Moderation: M. Bucher, Halle
19:00 Sepsis vermeiden und früh erkennen
F. M. Brunkhorst, Jena
Friday, 11 March 2016
Novel approaches to sepsis control and health promotion
Chairs: B. Böttiger, Cologne / B. Löffler, Jena
08:30 The US approach to quality improvement for sepsis management
- M. Levy, USA
08:50 Challenges to fight sepsis - in Greece
- E. Giamarellos-Bourboulis, Greece
09:10 Prepardness and the role of ICUs in the fight against pandemics
- J. Marshall, Canada
09:30 The Turkish approach to improve sepsis awareness and sepsis management
- N. Unal, Turkey
09:50 The Initiative for Quality in Medicine's approach
- A. Meier-Hellmann, Erfurt
10:10 The role of media during health crises
- J. Müller-Jung, FAZ
10:30 Coffee break
Roadmap for development of innovative vaccines, diagnostics and therapeutics I
Chairs: T. Koch, Dresden / L. Gattinoni, Milan
11:00 The German Center for Infection Research
- D. Heinz, DZIF
11:20 The German Research Platform for Zoonoses
- T. Mettenleiter, Greifswald
11:40 The SepNet Critical Care Trials group
- J. Briegel, Munich
12:00 The CapNetz Trials group
- T. Welte, Hannover
12:20 Lunch break
Roadmap for development of innovative vaccines, diagnostics and therapeutics II
Chairs: J. Schüttler, Erlangen / B. Löffler, Jena
13:00 The Progress Consortium
- N. Suttorp, Berlin
13:20 The Center for Sepsis Control and Care
- M. Bauer, Jena
13:40 The InfectControl Consortium
- A. Brakhage, Jena
14:00 The InfectoGnostics Research Campus
- J. Popp, Jena
14:20 The Center for Innovation Competence Septomics
- O. Kurzai, Jena
14:40 The Center for Infectious Diseases and Infection Control
- M. Pletz, Jena
15:00 Coffee break
Role of private public partnership for development of innovative vaccines, diagnostics and therapeutics
Lessons learned and expectations of:
Chairs: M. Hecker, Greifswald / H. van Aken, Münster
15:30 A researcher and later entrepreneur
- E. Ermantraut, Blink GmbH Jena
15:50 An international diagnostics corporate
- V. Liebenberg, Thermo Fisher Scientific Hennigsdorf/Berlin
16:10 A global medical products manufacturer
- M. Lugan, B. Braun Melsungen AG
16:30 A biotech company
- J. Struck, AdrenoMed AG Hennigsdorf/Berlin
16:50 A university spin-off
- N. Riedemann, inflaRx Jena
17:10 Closing remarks
- M. Bauer, Jena